Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder

Key information made simple

This observational study is following people with Treatment of catatonia in with unipolar depression, bipolarity or psychosis, that do not sufficiently benefit from treatment with lorazepam or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.